October 2021 First Publication from OSE Immunotherapeutics on the Role of SIRPα in the Induction and Maintenance of Immune Tolerance
October 2021 OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Use of Tedopi® to Treat Brain Metastasis
October 2021 OSE Immunotherapeutics to Present at 5th Annual Immuno-Oncology: BD&L and Investment Forum
October 2021 OSE Immunotherapeutics Receives Notice of Allowance for New U.S. Patent Protecting OSE-127